Heart failure & cardiomyopathiesCohort study

Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

Eur J Prev CardiolPublished

  • Prospective cohort study
  • matched controls

Authors' conclusion

Among cancer survivors, we observed a graded inverse association between the level of joint risk factor control and the risk of HF.

Study context

Population
Cancer survivors, UK Biobank, with matched controls without cancercancer survivors + matched controls
Exposure
Degree of joint risk factor control among cancer survivors
  • Matched controlsn = 57,864
Outcome
Incident HF
Follow-up
Median 12.54 years

Main finding

As reported in the abstract

Hazard ratio (95% CI)
Each additional controlled risk factor12% reduction per factor; adjusted
0.88(0.81–0.96)
≥5 risk factors controlled vs Lowest risk factor control24% lower HF risk
0.76(0.61–0.95)
Heart failure (HF) events: cancer survivors
572
HF events: matched controls
1851

Observational data: associations, not effects.

Original publication

Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study. Eur J Prev Cardiol. Published 13 November 2025. doi:10.1093/eurjpc/zwaf711

Summarised from the published abstract; every number is checked against it